Enabling Effective Management of Neonatal Jaundice in Rural India
Stanford University, 2009 - $46,500
If left untreated, neonatal jaundice can cause kernicterus, a form of brain damage with complications including deafness, cerebral palsy, and death. In the US, phototherapy treatment (shining wavelength-specific light on the baby) has virtually eliminated kernicterus, but in developing countries like India only a small segment of the population has access to effective treatment.
In order to improve patient access to neonatal jaundice treatment in rural Indian clinics, this team - working with the non-profit technology incubator, Design Revolution - is developing a low cost, low maintenance opto-medical device. Instead of using fluorescent tube or compact fluorescent bulbs, the team’s device uses more efficient, high-intensity blue LEDs that can be supported by a battery backup.
- Brilliance in India: New deal allows Bay-area firm to fight neonatal jaundice in rural India - Fast Company (Jan 2011)
- September 2012: Brilliance is on the market in India and they are looking to expand to East Africa. The team estimates that 13 babies per device per month will get treatment in urban hospitals, which means lives saved and brain damage averted.
- About NCIIA
- Meet our grantees
- For students
- For faculty
- Specialty training programs
- Annual conference
- NCIIA in the news